BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34530556)

  • 1. [Definition of tumor rupture in gastrointestinal stromal tumor].
    Zhou YB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):762-768. PubMed ID: 34530556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Tumor Rupture in Gastrointestinal Stromal Tumor.
    Nishida T; Hølmebakk T; Raut CP; Rutkowski P
    Ann Surg Oncol; 2019 Jun; 26(6):1669-1675. PubMed ID: 30868512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.
    Hølmebakk T; Hompland I; Bjerkehagen B; Stoldt S; Bruland ØS; Hall KS; Boye K
    Ann Surg Oncol; 2018 May; 25(5):1133-1139. PubMed ID: 29435684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preoperative tumor rupture timing on gastrointestinal stromal tumor prognosis: a retrospective multicentric cohort study.
    Chiguchi G; Cho H; Sato S; Takahashi T; Nabeshima K; Maruyama T; Kataoka M; Katayanagi S; Kikuchi H
    Jpn J Clin Oncol; 2022 Mar; 52(3):237-243. PubMed ID: 34933335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 6. Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.
    Hølmebakk T; Bjerkehagen B; Boye K; Bruland Ø; Stoldt S; Sundby Hall K
    Br J Surg; 2016 May; 103(6):684-691. PubMed ID: 26988241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
    J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.
    Hølmebakk T; Bjerkehagen B; Hompland I; Stoldt S; Boye K
    Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
    JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
    Wu X; Li J; Xu W; Gao J; Li Y; Shen L
    Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?
    Lu J; Dai Y; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
    Medicine (Baltimore); 2019 Jan; 98(3):e14177. PubMed ID: 30653164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
    Kim JS; Kim HJ; Park SH; Lee JS; Kim AY; Ha HK
    Eur Radiol; 2017 Jun; 27(6):2583-2590. PubMed ID: 27761711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
    Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
    Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
    Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
    World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence risk after resection of gastrointestinal stromal tumors: size is not all that matters... The consequences of tumor rupture.
    Han D; Deneve J; Gonzalez RJ
    Am Surg; 2012 Jan; 78(1):74-9. PubMed ID: 22273319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and prognosis of 108 patients with high-risk gastrointestinal stromal tumor].
    Lei C; Liu L; Wang Q; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1300-1304. PubMed ID: 27928804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of tumor rupture in gastrointestinal stromal tumor.
    Nishida T; Gotouda N; Takahashi T; Cao H
    J Dig Dis; 2023 May; ():. PubMed ID: 37210619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.
    Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA
    Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.